Aims Optimal endovascular management of intermittent claudication (IC) remains disputed.
This systematic review and meta-analysis compares efficacy and safety outcomes for …

Drug-eluting stents have transformed the treatment of coronary artery disease (CAD), and
there are two types: polymer-free and polymer-coated stents. Polymer-free stents have a …

BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …

Background: A clear patency benefit of a drug-eluting stent (DES) over bare metal stents
(BMSs) for treating peripheral artery disease of the femoropopliteal segment has not been …

Purpose: A late increased mortality risk has been reported in a summary level meta-analysis
of patients with femoropopliteal artery occlusive disease treated with paclitaxel-coated …

Objective Endovascular technology innovation requires rigorous evaluation in high quality
randomised controlled trials (RCTs). However, due to numerous methodological challenges …

Objective In recent years, studies of drug-eluting stent (DES) for femoropopliteal artery
diseases (FPADs) have been gradually published. To explore whether this type of stent is …

Coated stents are defined as innovative stents surrounded by a thin polymer membrane
based on polytetrafluoroethylene (PTFE) useful in the treatment of numerous vascular …

Objective: Indications for endovascular treatment of femoropopliteal (FP) lesions have
steadily increased over the past decade. Accordingly, the number of devices has also …

Immunotherapy has emerged as a pioneering therapeutic approach that harnesses the
immune system's abilities to combat diseases, particularly in the field of oncology where it …